Global Generic Drugs Market By Revenue Model (Prescription Products, Over the Counter (OTC) Products); By Application (Respiratory, Dermatology, Oncology, Diabetes, Infectious diseases, Ophthalmology, Women’s Health, Central Nervous System (CNS), Cardiovascular, Urology, Others (Pain Management, etc.)); By Form (Tablets, Capsules, Injectables, Topical Creams, Others); By Distribution Channel (Retail Pharmacy, Hospital Pharmacy); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Report ID :AMI-603 | Category : Healthcare | Published Date : July, 2020 | Pages : 402 | Format :PDF